Michael J Fox Foundation Announces Significant Breakthrough in Search for Parkinson s Biomarker michaeljfox.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from michaeljfox.org Daily Mail and Mail on Sunday newspapers.
The Michael J. Fox Foundation for Parkinson's Research (MJFF), confirms the most significant breakthrough yet in the search for a Parkinson's biomarker: a biological test for Parkinson's disease that demonstrates high diagnostic accuracy, differentiates molecular subtypes and detects disease in individuals before cardinal movement symptoms arise. The new test, known as the alpha-synuclein seed amplification assay (?Syn-SAA), heralds the revolutionary ability for research to define Parkinson's disease biologically, offering a critical tool for clinical trial design and assessment of treatment effects, and for early detection of disease pathology.
New paper in The Lancet Neurology confirms that a key Parkinson s pathology can now be identified by examining spinal fluid from living patients Test validated.
New paper in The Lancet Neurology confirms that a key Parkinson's pathology can now be identified by examining spinal fluid from living patientsTest validated in the gold-standard Parkinson's
New paper in The Lancet Neurology confirms that a key Parkinson s pathology can now be identified by examining spinal fluid from living patients Test validated.